ENDRA Life Sciences Inc. (NDRA)
$5.01
$-0.40
(-7.40%)
As on 28-Aug-2026 16:00EDT
Market cap
$8 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.1
-
Debt to Equity
0
-
Book Value
$4.2
-
EPS
$-7.2
-
Face value
--
-
Shares outstanding
1,499,838
10 Years Aggregate
CFO
$-67.36 Mln
EBITDA
$-71.20 Mln
Net Profit
$-84.38 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
| 10.5 | 4.7 | -6.6 | 21.8 | -86.2 | -85.0 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
| -27.6 | -99.8 | -47.9 | -70.6 | -7.7 | -55.4 | 12.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
|
5.0 | 7.5 | 0.0 | -5.9 | -- | -138.1 | -- | 1.3 |
| 84.9 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 247.9 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 72.1 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.5 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 105.4 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 351.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 533.8 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 600.7 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 344.8 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout ENDRA Life Sciences (NDRA)
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio... frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Read more
-
Chairman, President & CEO
Mr. Francois Michelon
-
Chairman, President & CEO
Mr. Francois Michelon
-
Headquarters
Ann Arbor, MI
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ENDRA Life Sciences (NDRA)
What is the current share price of ENDRA Life Sciences Inc (NDRA) Today?
The share price of ENDRA Life Sciences Inc (NDRA) is $5.01 (NASDAQ) as of 28-Aug-2026 16:00 EDT. ENDRA Life Sciences Inc (NDRA) has given a return of -86.25% in the last 3 years.
What is the current PB & PE ratio of ENDRA Life Sciences Inc (NDRA)?
Since, TTM earnings of ENDRA Life Sciences Inc (NDRA) is negative, P/E ratio is not available.
The P/B ratio of ENDRA Life Sciences Inc (NDRA) is 1.28 times as on 28-Aug-2026, a 76 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.51 |
1.58 |
2024 |
-0.29 |
1.31 |
2023 |
-0.36 |
0.64 |
2022 |
-0.60 |
1.09 |
2021 |
-0.13 |
0.13 |
What is the 52 Week High and Low of ENDRA Life Sciences Inc (NDRA)?
The 52-week high and low of ENDRA Life Sciences Inc (NDRA) are Rs 9.85 and Rs 2.96 as of 30-Aug-2026.
What is the market cap of ENDRA Life Sciences Inc (NDRA)?
ENDRA Life Sciences Inc (NDRA) has a market capitalisation of $ 8 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in ENDRA Life Sciences Inc (NDRA)?
Before investing in ENDRA Life Sciences Inc (NDRA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.